Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.00
-0.06 (-1.19%)
At close: Oct 9, 2025, 4:00 PM EDT
4.970
-0.030 (-0.60%)
After-hours: Oct 9, 2025, 4:03 PM EDT

Taysha Gene Therapies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
1,3603553311414481,002
Upgrade
Market Cap Growth
226.87%7.14%134.50%-68.52%-55.28%-
Upgrade
Enterprise Value
1,148260227170314724
Upgrade
Last Close Price
5.061.731.772.2611.6526.54
Upgrade
PS Ratio
172.4542.5521.4256.40--
Upgrade
PB Ratio
5.554.964.42148.704.703.99
Upgrade
P/TBV Ratio
5.634.964.42148.704.703.99
Upgrade
EV/Sales Ratio
141.7431.1914.6767.98--
Upgrade
Debt / Equity Ratio
0.240.890.8263.150.66-
Upgrade
Asset Turnover
0.030.050.100.02--
Upgrade
Quick Ratio
12.345.303.921.402.8835.24
Upgrade
Current Ratio
12.485.424.081.543.0836.17
Upgrade
Return on Equity (ROE)
-51.86%-121.94%-294.04%-344.67%-100.68%-47.79%
Upgrade
Return on Assets (ROA)
-20.88%-32.51%-29.84%-46.30%-45.80%-20.76%
Upgrade
Return on Capital (ROIC)
-23.43%-39.93%-45.31%-71.82%-52.85%-21.40%
Upgrade
Earnings Yield
-6.62%-25.19%-33.71%-117.64%-38.94%-5.99%
Upgrade
FCF Yield
-5.89%-23.02%-23.23%-77.25%-29.53%-3.07%
Upgrade
Buyback Yield / Dilution
-37.81%-115.41%-164.20%-16.74%-113.13%-83.53%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q